Linaclotide vs P11-4
Head-to-head comparison of Linaclotide (Linaclotide) and P11-4 (Self-assembling peptide P11-4 (Ac-QQRFEWEFEQQ-NH2)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Linaclotide | P11-4 |
|---|---|---|
| Category | Gastrointestinal | Dental & Oral |
| Full Name | Linaclotide | Self-assembling peptide P11-4 (Ac-QQRFEWEFEQQ-NH2) |
| Molecular Weight | 1526.8 Da | 1466 Da |
| Half-Life | Active locally; negligible systemic half-life | local activity for hours; peptide degraded over time |
| Amino Acids | 14 | 11 |
| Typical Dose | 72-290 mcg once daily | 0.5-5 mg per lesion |
| Route | Oral | Topical/Intraoral |
| Purity | ≥98% | ≥98% |
| Studies Count | 1200 | 40 |
| Research Status | Clinical | Clinical |
Linaclotide Benefits
- ✓improves-bowel-movements
- ✓reduces-abdominal-pain
- ✓increases-intestinal-secretion
- ✓supports-transit
P11-4 Benefits
- ✓enamel remineralization
- ✓early caries arrest
- ✓biomimetic scaffold formation
- ✓minimally invasive repair
Linaclotide Dosing
72 mcg PO daily|145 mcg PO daily|290 mcg PO daily
P11-4 Dosing
topical application to cleaned lesion|single-visit in-office application|repeat at follow-up if indicated
Linaclotide Side Effects
- ⚠diarrhea
- ⚠abdominal-pain
- ⚠bloating
P11-4 Side Effects
- ⚠transient tooth sensitivity
- ⚠local irritation
- ⚠taste disturbance
Research Overview
Linaclotide
Linaclotide has extensive clinical evidence for chronic idiopathic constipation and IBS-C, with consistent effects on stool frequency and abdominal symptom relief. Its mechanism is local GC-C activation in the gut with minimal systemic exposure.
P11-4
P11-4 has been studied for its ability to penetrate initial carious lesions and self-assemble into a fibrillar matrix that nucleates hydroxyapatite. Human and preclinical studies support its role in non-invasive enamel repair.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.